- VRNA Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
Verona Pharma (VRNA) 8-K27 Jun 24Ohtuvayre is indicated for the maintenance treatment of COPD allowing for broad use in COPD patientsFinancial data
Company Profile